CN104136601A - 人视网膜祖细胞的表型谱 - Google Patents

人视网膜祖细胞的表型谱 Download PDF

Info

Publication number
CN104136601A
CN104136601A CN201380007641.3A CN201380007641A CN104136601A CN 104136601 A CN104136601 A CN 104136601A CN 201380007641 A CN201380007641 A CN 201380007641A CN 104136601 A CN104136601 A CN 104136601A
Authority
CN
China
Prior art keywords
cell
cells
cell mass
purifying
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380007641.3A
Other languages
English (en)
Chinese (zh)
Inventor
迈克尔·J·杨
彼得·Y·巴拉诺夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schepens Eye Research Institute Inc
Original Assignee
Schepens Eye Research Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schepens Eye Research Institute Inc filed Critical Schepens Eye Research Institute Inc
Priority to CN201810203142.6A priority Critical patent/CN108588025A/zh
Publication of CN104136601A publication Critical patent/CN104136601A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
CN201380007641.3A 2012-02-17 2013-02-15 人视网膜祖细胞的表型谱 Pending CN104136601A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810203142.6A CN108588025A (zh) 2012-02-17 2013-02-15 人视网膜祖细胞的表型谱

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261600288P 2012-02-17 2012-02-17
US61/600,288 2012-02-17
PCT/US2013/026286 WO2013123292A1 (en) 2012-02-17 2013-02-15 Phenotype profile of human retinal progenitor cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201810203142.6A Division CN108588025A (zh) 2012-02-17 2013-02-15 人视网膜祖细胞的表型谱

Publications (1)

Publication Number Publication Date
CN104136601A true CN104136601A (zh) 2014-11-05

Family

ID=48984730

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201810203142.6A Pending CN108588025A (zh) 2012-02-17 2013-02-15 人视网膜祖细胞的表型谱
CN201380007641.3A Pending CN104136601A (zh) 2012-02-17 2013-02-15 人视网膜祖细胞的表型谱

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201810203142.6A Pending CN108588025A (zh) 2012-02-17 2013-02-15 人视网膜祖细胞的表型谱

Country Status (10)

Country Link
US (3) US10758572B2 (enExample)
EP (2) EP3492586B1 (enExample)
JP (2) JP6468843B2 (enExample)
KR (1) KR20140144680A (enExample)
CN (2) CN108588025A (enExample)
AU (3) AU2013221458B2 (enExample)
BR (1) BR112014019328A8 (enExample)
CA (1) CA2864818C (enExample)
ES (1) ES2700980T3 (enExample)
WO (1) WO2013123292A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106323845A (zh) * 2015-06-23 2017-01-11 何伟 鉴定具有治疗视网膜退行性病变功能的视网膜祖细胞的方法与试剂盒

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492586B1 (en) 2012-02-17 2024-04-17 Schepens Eye Research Institute Phenotype profile of human retinal progenitor cells
CN105814192A (zh) 2013-10-09 2016-07-27 加利福尼亚大学董事会 哺乳动物视网膜干细胞产生方法和应用
KR101690759B1 (ko) * 2015-02-25 2016-12-30 연세대학교 산학협력단 전능성 줄기세포로부터 중간엽 줄기세포를 수득하는 방법
AU2016318774B2 (en) * 2015-09-08 2022-08-18 FUJIFILM Cellular Dynamics, Inc. MACS-based purification of stem cell-derived retinal pigment epithelium
GB201615714D0 (en) * 2016-09-15 2016-11-02 Univ Of Sheffield The Otic progenitor identification and isolation
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
WO2020190848A1 (en) * 2019-03-15 2020-09-24 The Schepens Eye Research Institute, Inc. Isolation, enrichment and expansion of cone progenitor cells and uses thereof
EP4518877A1 (en) * 2022-05-06 2025-03-12 The Schepens Eye Research Institute, Inc. Isolation, enrichment, and expansion of human rod progenitor cells and extracellular vesicles derived therefrom

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1968608A (zh) * 2004-01-23 2007-05-23 先进细胞技术公司 用于治疗视网膜变性病的改良模式

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
FR2636968B1 (fr) 1988-09-27 1992-01-03 Inst Nat Sante Rech Med Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle
DE69123241T2 (de) 1990-12-14 1997-04-17 Cell Genesys Inc Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US6071889A (en) 1991-07-08 2000-06-06 Neurospheres Holdings Ltd. In vivo genetic modification of growth factor-responsive neural precursor cells
US5750376A (en) 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US5980885A (en) 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. Growth factor-induced proliferation of neural precursor cells in vivo
US5981165A (en) 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
US5654183A (en) 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
NZ256154A (en) 1992-07-27 1997-02-24 California Inst Of Techn Production of mammalian multipotent neural stem cells, antibodies
US5693482A (en) 1992-07-27 1997-12-02 California Institute Of Technology Neural chest stem cell assay
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
ATE221117T1 (de) 1992-10-16 2002-08-15 Neurospheres Holdings Ltd Remyelination unter verwendung von neuronalen stammzellen
PT669973E (pt) 1992-10-28 2003-06-30 Neurospheres Holdings Ltd Factores biologicos e celulas estaminais neurais
FR2699191B1 (fr) 1992-12-16 1995-02-10 Univ Paris Curie Nouveaux vecteurs rétroviraux, lignées cellulaires les contenant, et leur utilisation dans le traitement des tumeurs.
JP3583778B2 (ja) 1993-01-29 2004-11-04 ニューロスフィアーズ ホウルディングス リミテッド 神経幹細胞の遺伝子修飾
US6033906A (en) 1993-07-26 2000-03-07 California Institute Of Technology Methods for differentiating neural stem cells to glial cells using neuregulins
JPH09509564A (ja) 1993-11-09 1997-09-30 ターゲテッド ジェネティックス コーポレイション 高力価組換えａａｖベクターの生成
ES2189807T3 (es) 1993-11-09 2003-07-16 Neurospheres Holdings Ltd Modificacion y manipulacion in situ de celulas madre del sistema nervioso central.
US6001654A (en) 1994-01-28 1999-12-14 California Institute Of Technology Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5935849A (en) 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5853717A (en) 1994-07-20 1998-12-29 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
DK0783693T3 (da) 1994-09-23 2002-01-14 Neurospheres Holdings Ltd In vitro-modeller for CNS-funktion og -dysfunktion
CN1170435A (zh) 1994-11-14 1998-01-14 纽罗斯菲里斯控股有限公司 神经干细胞增殖的调节
US5861283A (en) 1995-03-31 1999-01-19 The University Of Medicine And Dentistry Of New Jersey DNA encoding a limbic system-associated membrane protein
CA2249417A1 (en) 1996-03-26 1997-10-02 Brent A. Reynolds Manipulation of mitotically active cells of the hippocampal region of the brain
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
CA2216439A1 (en) 1996-09-25 1998-03-25 Derek Van Der Kooy Pharmaceuticals containing retinal stem cells
US6908763B1 (en) 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6093531A (en) 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
US6165783A (en) 1997-10-24 2000-12-26 Neuro Spheres Holdings Ltd. Erythropoietin-mediated neurogenesis
WO1999055838A1 (en) 1998-04-24 1999-11-04 University Of Nebraska Board Of Regents Compositions and methods for the characterization and transplantation of mammalian retinal stem cells
US6171610B1 (en) 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
US5958767A (en) 1998-08-14 1999-09-28 The Children's Medical Center Corp. Engraftable human neural stem cells
US6184035B1 (en) 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
AU3594400A (en) 1999-02-11 2000-08-29 Salk Institute For Biological Studies, The Isolation of stem cells and methods of use thereof
US6468794B1 (en) 1999-02-12 2002-10-22 Stemcells, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
DE60142553D1 (de) * 2000-02-11 2010-08-26 Children S Hospital Of Orange Isolierung und transplantation von retinalen stammzellen
US20030108925A1 (en) * 2001-10-05 2003-06-12 U.S. Epa Genetic testing for male factor infertility
US6638369B1 (en) 2002-05-07 2003-10-28 The United States Of America As Represented By The Secretary Of The Navy Non-chromate conversion coatings
KR100818689B1 (ko) * 2003-03-10 2008-04-02 도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 간엽계 간세포의 식별방법
WO2005123909A2 (en) 2004-06-09 2005-12-29 The Board Of Trustees Of The Leland Stanford Junior University Isolation and characterization of muscle regenerating cells
ES2621847T3 (es) * 2004-12-23 2017-07-05 DePuy Synthes Products, Inc. Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
US9061017B2 (en) 2006-05-03 2015-06-23 The Schepens Eye Research Institute, Inc. Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues
US7781179B2 (en) 2006-12-07 2010-08-24 The Board Of Trustees Of The Leland Stanford Junior University Identification and isolation of transitional cell carcinoma stem cells
US20100318193A1 (en) 2007-03-08 2010-12-16 Desai Tejal A Topographically engineered structures and methods for using the same in regenerative medicine applications
CA3207103A1 (en) * 2007-07-31 2009-02-05 Janssen Biotech, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
WO2009042209A2 (en) * 2007-09-25 2009-04-02 The Board Of Trustees Of The Leland Stanford Junior University Identification of thymically derived cd4 t cells by protein tyrosine kinase 7 expression
US8368588B2 (en) 2007-11-26 2013-02-05 Mediatek Inc. Method and apparatus for updating transformation information parameters used in global navigation satellite system
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
CA2721952C (en) * 2008-04-22 2019-11-12 Regenerative Research Foundation Retinal pigment epithelial stem cells
US20110004304A1 (en) 2009-03-20 2011-01-06 Tao Sarah L Culturing retinal cells and tissues
CA3066806C (en) 2009-08-24 2023-03-07 David M. Gamm Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
ES2542226T3 (es) 2010-04-28 2015-08-03 Technische Universität Dresden Método para producir células progenitoras retinianas polarizadas a partir de células madre pluripotentes y su diferenciación para dar células del epitelio pigmentario retiniano
CN111265551A (zh) * 2011-05-18 2020-06-12 加利福尼亚大学董事会 用于治疗视网膜疾病的组合物及方法
US8563304B2 (en) 2011-06-14 2013-10-22 The Schepens Eye Research Institute Low oxygen culture conditions for maintaining retinal progenitor cell multipotency
WO2012177968A1 (en) 2011-06-22 2012-12-27 The Schepens Eye Research Institute, Inc. A scaffold for subretinal cell transplantation and drug delivery
US20130189341A1 (en) * 2012-01-23 2013-07-25 Caio Regatieri Generation of photoreceptors from human retinal progenitor cells using polycaprolactone substrates
EP3492586B1 (en) 2012-02-17 2024-04-17 Schepens Eye Research Institute Phenotype profile of human retinal progenitor cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1968608A (zh) * 2004-01-23 2007-05-23 先进细胞技术公司 用于治疗视网膜变性病的改良模式

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HIDETO KOSO ET AL.: "SSEA-1 marks regionally restricted immature subpopulations of embryonic retinal progenitor cells that are regulated by the Wnt signaling pathway", 《DEVELOPMENTAL BIOLOGY》 *
JAN PRUSZAK ET AL.: "Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations", 《STEM CELLS》 *
KLASSEN H ET AL.: "Isolation of retinal progenitor cells from post-mortem human tissues and comparison with autologous brain progenitors", 《JOURNAL OF NEUROSCIENCE RESEARCH》 *
MARIA BEATRIZ HERRERA ET AL.: "Isolation and characterization of a stem cell population from adult human liver.", 《STEM CELLS》 *
UNBER AFTAB ET AL.: "Growth kinetics and transplantation of human retinal progenitor cells", 《EXPERIMENTAL EYE RESEARCH》 *
万瑾等: "视网膜祖细胞干细胞特性及移植入视网膜后的研究", 《解剖学杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106323845A (zh) * 2015-06-23 2017-01-11 何伟 鉴定具有治疗视网膜退行性病变功能的视网膜祖细胞的方法与试剂盒

Also Published As

Publication number Publication date
AU2018214122C1 (en) 2021-08-19
EP2814947A4 (en) 2015-08-12
AU2021204404A1 (en) 2021-07-22
AU2021204404B2 (en) 2024-05-02
EP2814947A1 (en) 2014-12-24
WO2013123292A9 (en) 2015-01-08
CA2864818C (en) 2022-05-03
JP2019013243A (ja) 2019-01-31
US20150017133A1 (en) 2015-01-15
CN108588025A (zh) 2018-09-28
BR112014019328A8 (pt) 2017-07-11
US11957719B2 (en) 2024-04-16
AU2013221458A1 (en) 2014-08-07
US10758572B2 (en) 2020-09-01
CA2864818A1 (en) 2013-08-22
ES2700980T3 (es) 2019-02-20
EP3492586B1 (en) 2024-04-17
AU2013221458B2 (en) 2018-08-30
US20200345785A1 (en) 2020-11-05
EP2814947B1 (en) 2018-11-21
AU2018214122A1 (en) 2018-08-30
AU2018214122B2 (en) 2021-04-01
EP3492586A1 (en) 2019-06-05
JP2015508656A (ja) 2015-03-23
WO2013123292A1 (en) 2013-08-22
BR112014019328A2 (enExample) 2017-06-20
JP6468843B2 (ja) 2019-02-13
KR20140144680A (ko) 2014-12-19
US20250161366A1 (en) 2025-05-22

Similar Documents

Publication Publication Date Title
US20250161366A1 (en) Phenotype profile of human retinal progenitor cells
US8241897B2 (en) Isolation of neural stem cells using gangliosides and other surface markers
JP6997716B2 (ja) 間葉系マーカーおよびニューロンマーカーを発現する幹細胞、その組成物、ならびにその調製方法
CN102858951A (zh) 可从机体组织分离的多能干细胞
JP2014509319A (ja) 臍由来細胞を使用する筋萎縮性側索硬化症の治療
JP2022513736A (ja) 多能性幹細胞由来の臨床グレードの角膜内皮細胞の作製および凍結保存
JP4576545B2 (ja) 羊膜由来因子による胚性幹細胞の培養方法
US20190030083A1 (en) Neural stem cells and uses thereof
CN112334574A (zh) 用于产生视网膜色素上皮细胞的方法和组合物
US20240424028A1 (en) Neural stem cells and uses thereof
CN120857934A (zh) 一种用于预防和/或治疗与脑血流减少相关的疾病或状态的药物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141105

RJ01 Rejection of invention patent application after publication